RegiPharm

  • Orthodox / Allopathic Medicines

    There are particular requirements and processes involved during the registration process for medicines in South Africa and we offer the following services...

  • Complementary Medicines

    Our aim is to clarify the often confusing issues surrounding the complementary medicines industry. We assist our clients to comply with the current requirements for their individual needs. Our clients have come to rely on our expert advice and prompt service.

  • Cosmetics

    We can assist with evaluation of ingredients, claims, advertisements and labelling, taking into account the ASA (Advertising Standards Authority) Code of Advertising Practice.

  • Foodstuffs

    All foodstuffs are controlled by the Foodstuffs, Cosmetics and Disinfectants Act, Act 54 of 1972, which controls the manufacture, importation, marketing and sale of foodstuffs.

  • Veterinary Medicines, Farm Feeds and Stock Remedies

    There are particular requirements and processes involved during the registration process in South Africa we can assist with the following...

  • Licensing of Facilities and GMP

    Depending on the business and its intended activities, all pharmaceutical companies in South Africa require licensing with both the Medicines Control Council and the Department of Health.

Complementary Medicines

Our aim is to clarify the often confusing issues surrounding the complementary medicines industry. We assist our clients to comply with the current requirements for their individual needs. Our clients have come to rely on our expert advice and prompt service.

Complementary medicines are subdivided into the following classes:

  • Anthroposophical medicines;
  • Aromatherapeutic essential oils;
  • Ayurvedic medicines;
  • Biochemic tissue salts;
  • Chinese medicines;
  • Gemmotherapeutic substances;
  • Flower and gem essences;
  • Herbal medicines
  • Homoeopathic medicines;
  • Homotoxicological medicines;
  • Mineraloid substances;
  • Nutraceuticals;
  • Nutritional food substances;
  • Sowa Rigpa medicines; and
  • Unani-Tibb medicines.

The Biodiversity Act (Act 10 of 2004)

In ensuring sustainable utilisation of indigenous and endemic biological resources, while promoting fair and equitable sharing of benefits, the National Department of Environmental Affairs through the National Environmental Management: Biodiversity Act (NEMBA), Act 10 of 2004 developed the Bioprospecting, Access and Benefit Sharing Regulations which came into force on 1 April 2008.

These regulations govern the utilisation of indigenous biological resources or associated traditional knowledge, targeted for research and development (bioprospecting), with an intention to commercialise the end product - through a permitting systems.

You are here: RegiPharm // Complementary Medicines